Acute Porphyria Drug Database

Monograph

J06BD01 - Palivizumab
Not porphyrinogenic
NP

Rationale
Immunoglobulin
Chemical description
Humanized IgA monoclonal antibody against RSV-virus.

Similar drugs
Explore alternative drugs in similar therapeutic classes J06B / J06BD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Synagis · Synagis 100 mg/ml, oplossing voor injectie
Belgium
Synagis · Synagis 100 mg/ml sol. inj. i.m. flac.
United Kingdom
Synagis · Synagis 100mg powder and solvent for solution for injection vials · Synagis 100mg/1ml solution for injection vials · Synagis 50mg powder and solvent for solution for injection vials · Synagis 50mg/0.5ml solution for injection vials
Denmark
Synagis
Norway
Synagis
Poland
Synagis
Luxembourg
Synagis
Iceland
Synagis
Finland
Synagis
Latvia
Synagis
Serbia
Synagis · Synagis®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙